Skip to main content
OpenTrials
Completed

NCT Number: NCT05087394

COVID19 Hospitilized in Clinica Pasteur of Neuquen (Argentina)

retrospective cohort (non-experimental study) of COVID 19 patients assisted in hospitalization (severe and critical) between 2020 and 2021

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Pasteur Clinic

Neuquén, Nqn, 8300, Argentina

About this study

Consecutive patients with acute infection by SARS-COV2 and severe or critical COVID19 disease, or acute complications, hospitalized in the Pasteur Clinic of Neuquén city from the beginning of the pandemic in the region until December 31, 2021. Data were obtained retrospectively from information registered simultaneously with hospitalization in three databases (RedCap, DataTech and Excel).

. Inclusion criteria

  • Adult patients (over 18 years old)
  • Suffering from acute infection by SARS-Cov2, diagnosed by PCR-real time, detection of viral antigen, specific antibodies with or clinical epidemiological criteria
  • Hospitalized defined by attending physicians or referral (severe or critical according to NIH) Exclusion criteria
  • Patients under 18 years of age.
  • Convalescent from acute SARS-Cov2 infection and without evidence of a new event of reinfection.
  • Outpatient management or hospitalization less than 24 hours for diagnosis and / or evaluation of severity or complications. Sample Selection Method First patient was registered at the beginning of the pandemic in the region March 20, 2020) and is expected to recruit the las patient diagnosed in December 31, 2021.

The recruitment is consecutive without other selection criteria.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients (over 18 years old)
  • Suffering from acute infection by SARS-Cov2, diagnosed by PCR-real time, detection of viral antigen, specific antibodies with or clinical epidemiological criteria
  • Hospitalization defined by attending or referral physician (severe or critical according to NIH)

Exclusion criteria

  • Patients under 18 years of age.
  • Convalescent from acute SARS-Cov2 infection and without evidence of a new event reinfection.
  • Outpatient management or hospitalization less than 24 hours for diagnosis and / or evaluation of severity or complications.

Treatment and study plan

Comorbidities

Other

Risk factors (comorbidities), requirements of respiratory suppot and chest imaging will are considered exposure for primary outcomes

Other names: Oxigen requirement, Mechanical Ventilation, High flow nasal cannula, Chest CT scan, CT pulmonary angiogram (CTPA)

Primary outcomes

  1. 28-day mortality

    Time frame: From date of admition until the date of death from any cause, assessed up to 28 day

    defined as death ocurred within 28 days of admition to hospital

  2. Hospital mortality

    Time frame: From date of admition until the date of death from any cause, assessed up to 52 weeks

    defined as death ocurred within hospitalization

Secondary outcomes

  1. Invasive Mechanical ventilation

    Time frame: From date of admition until the date of equirement of invasive mechanical ventilation, assessed up to 21 day

    defined as requirement of invasive mechanical ventilation support

Sponsors and collaborators

Lead sponsor

Asociacion Latinoamericana de Torax

Industry

Registry information

Official study title

Cohort of COVID19 Patients Admitted to Pasteur Clinic 2020-2021

Acronym: COVIDPas

Important dates

Study start
2020
Primary completion
2021
Study completion
2022
First posted
Oct 21, 2021
Registry last updated
Jan 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.